Media Coverage

Ozempic-utmanaren Sigrid Therapeutics backas med 45 miljoner – ska växa i USA

Nov 16, 2026

Media: Breakit

Breakit reports on Sigrid’s SEK 45 million funding round and the company’s plans to grow in the US market.

FundingUS expansionGrowth strategy
Ozempic-utmanaren Sigrid Therapeutics backas med 45 miljoner – ska växa i USA
Read the full article

Swedish tech outlet Breakit covered Sigrid’s SEK 45 million funding round, positioning the company as a challenger in the GLP-1 era and outlining its plans for expansion in the United States. The coverage points to strong investor confidence in the market opportunity for SiPore®.

← Back to all insights